Drug Name Mix-Ups Of Aricept/Azilect And Neulasta/Lunesta Under Investigation By FDA
This article was originally published in The Pink Sheet Daily
Confusion has occurred with oral and written orders, the Institute for Safe Medication Practices Medication Safety Alert reports.
You may also be interested in...
In partnership with PhRMA, FDA and the Institute for Safe Medication Practices have launched a campaign to prevent error-prone notation from appearing in labels and advertisements.
The virtual J.P. Morgan Healthcare meeting was missing the usual energy but still had substance.
US vaccination campaign will pick up speed now that access is broadening, leaders from Operation Warp Speed, Pfizer, Moderna, McKesson and CVS Health say at a J.P. Morgan panel discussion.